Clinical Trial Update: A Proof of Concept Study to Evaluate CN-105 in ICH Patients [Phase 2]

View source ↗

Summary

A Phase 2 proof-of-concept study evaluating CN-105 in patients with intracerebral hemorrhage has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intracerebral Hemorrhage

Drugs mentioned

• CN-105 (CN-105)

Snippet

Sponsor: AegisCN LLC | Conditions: Intracerebral Hemorrhage | Phase 2 | Status: COMPLETED